1. MAPK/ERK Pathway
  2. MAP4K
  3. GNE 220

GNE 220 

Cat. No.: HY-U00428
Handling Instructions

GNE-220 is a potent and selective inhibitor of MAP4K4 with an IC50 of 7 nM.

For research use only. We do not sell to patients.

GNE 220 Chemical Structure

GNE 220 Chemical Structure

CAS No. : 1199590-75-4

Size Stock
100 mg   Get quote  
250 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

Other In-stock Forms of GNE 220:

Other Forms of GNE 220:

Top Publications Citing Use of Products
  • Biological Activity

  • Protocol

  • Purity & Documentation

  • References

  • Customer Review


GNE-220 is a potent and selective inhibitor of MAP4K4 with an IC50 of 7 nM.

IC50 & Target[1]


7 nM (IC50)


9 nM (IC50)


1.1 μM (IC50)

In Vitro

GNE-220 also inhibits a few other kinases with IC50s of 9 nM, 476 nM and 1.1 μM for MINK (MAP4K6), DMPK and KHS1 (MAP4K5), respectively. GNE-220 alters human umbilical vein endothelial cells (HUVEC) sprout morphology. GNE-220 also reduces pERM+ retraction fibres in a dose-dependent manner. GNE-220 also dose-dependently increased the number of active-INTβ1+ long focal adhesions (FAs)[1].

Molecular Weight









Room temperature in continental US; may vary elsewhere.


Please store the product under the recommended conditions in the Certificate of Analysis.

Kinase Assay

His-tagged MAP4K4 kinase domain (A2-E328) is expressed and purified from SF9 insect cells. 3 μg of purified kinase containing a T181E activating mutation is incubated with 100 μM moesin peptide LGRDKYKTLRQIRQ or purified Myc-Flag-moesin in 50 mM HEPES pH 7.2/10 mM MgCl2/1 mM EGTA/0.01% Triton X-100 for 45 min at room temperature in the presence or absence of 3 μM ATP. Remaining ATP levels are assayed using KinaseGlo[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Assay

HUVECs are cultured in complete EGM-2 (CC-3156 and CC-4176). HUVEC are assayed 3 days after siRNA transfection. CHO cells (ATCC, CCL-61) are cultured in DMEM supplemented with 10% FBS, 1 mM Glutamate, and Penicillin/Streptomycin and transfected using Lipofectamine LTX. HUVEC sprouting assays are performed. For siRNA treatment, HUVECs are transfected 1 day before coating to beads. For chemical inhibitor (e.g., GNE-220, 0.1, 1, 10, 100, 1000 and 10000 nM) treatment, is added to media after fibrin is clotted. For immunofluorescence staining, beads are seeded in thin 100 μL fibrin clots. For scratch wound healing assay, HUVEC are transfected 2 days before re-seeding into a glass-bottom 96-wells plate[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2


GNE 220GNE220GNE-220MAP4KMAPK Kinase Kinase KinaseInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product name



Applicant name *


Email address *

Phone number *


Organization name *

Country or Region *


Requested quantity *


Bulk Inquiry

Inquiry Information

Product name:
GNE 220
Cat. No.:
MCE Japan Authorized Agent: